Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Sun

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Frontiers in Computational Neuroscience|April 9, 2020
Deep Learning-Based Concurrent Brain Registration and Tumor SegmentationThéo Estienne, Marvin Lerousseau, Maria Vakalopoulou, et al.
Oncoimmunology|May 10, 2019
Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapyRomain-David Seban, Charlotte Robert, Laurent Dercle, et al.
Journal for Immunotherapy of Cancer|February 17, 2021
Prospective development and validation of a liquid immune profile-based signature (LIPS) to predict response of patients with recurrent/metastatic cancer to immune checkpoint inhibitorsJian-Guo Zhou, Anna-Jasmina Donaubauer, Benjamin Frey, et al.
Gynecologic Oncology|November 12, 2022
Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: Clinical outcome and prognostic factorsKanta Ka, Adrien Laville, Elie Rassy, et al.
European Journal of Cancer (Oxford, England : 1990)|August 22, 2017
Baseline lymphopenia should not be used as exclusion criteria in early clinical trials investigating immune checkpoint blockers (PD-1/PD-L1 inhibitors)Roger Sun, Stéphane Champiat, Laurent Dercle, et al.
Cancers|April 3, 2021
Pulsed Dose Rate Brachytherapy of Lip Carcinoma: Clinical Outcome and Quality of Life AnalysisRadouane El Ayachy, Roger Sun, Kanta Ka, et al.
Physics and Imaging in Radiation Oncology|June 24, 2024
Automatic gross tumor volume segmentation with failure detection for safe implementation in locally advanced cervical cancerRahimeh Rouhi, Stéphane Niyoteka, Alexandre Carré, et al.
Journal for Immunotherapy of Cancer|October 28, 2022
Radiomics to evaluate interlesion heterogeneity and to predict lesion response and patient outcomes using a validated signature of CD8 cells in advanced melanoma patients treated with anti-PD1 immunotherapyRoger Sun, Marvin Lerousseau, Jade Briend-Diop, et al.
International Journal of Radiation Oncology, Biology, Physics|February 20, 2021
Systematic Screening of COVID-19 Disease Based on Chest CT and RT-PCR for Cancer Patients Undergoing Radiation Therapy in a Coronavirus French HotspotRoger Sun, Samir Achkar, Samy Ammari, et al.
Oncotarget|March 7, 2018
Locally advanced cervical cancer with bladder invasion: clinical outcomes and predictive factors for vesicovaginal fistulaeRoger Sun, Ines Koubaa, Elaine Johanna Limkin, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Frontiers in Computational Neuroscience|April 9, 2020
Deep Learning-Based Concurrent Brain Registration and Tumor SegmentationThéo Estienne, Marvin Lerousseau, Maria Vakalopoulou, et al.
Oncoimmunology|May 10, 2019
Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapyRomain-David Seban, Charlotte Robert, Laurent Dercle, et al.
Journal for Immunotherapy of Cancer|February 17, 2021
Prospective development and validation of a liquid immune profile-based signature (LIPS) to predict response of patients with recurrent/metastatic cancer to immune checkpoint inhibitorsJian-Guo Zhou, Anna-Jasmina Donaubauer, Benjamin Frey, et al.
Gynecologic Oncology|November 12, 2022
Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: Clinical outcome and prognostic factorsKanta Ka, Adrien Laville, Elie Rassy, et al.
European Journal of Cancer (Oxford, England : 1990)|August 22, 2017
Baseline lymphopenia should not be used as exclusion criteria in early clinical trials investigating immune checkpoint blockers (PD-1/PD-L1 inhibitors)Roger Sun, Stéphane Champiat, Laurent Dercle, et al.
Cancers|April 3, 2021
Pulsed Dose Rate Brachytherapy of Lip Carcinoma: Clinical Outcome and Quality of Life AnalysisRadouane El Ayachy, Roger Sun, Kanta Ka, et al.
Physics and Imaging in Radiation Oncology|June 24, 2024
Automatic gross tumor volume segmentation with failure detection for safe implementation in locally advanced cervical cancerRahimeh Rouhi, Stéphane Niyoteka, Alexandre Carré, et al.
Journal for Immunotherapy of Cancer|October 28, 2022
Radiomics to evaluate interlesion heterogeneity and to predict lesion response and patient outcomes using a validated signature of CD8 cells in advanced melanoma patients treated with anti-PD1 immunotherapyRoger Sun, Marvin Lerousseau, Jade Briend-Diop, et al.
International Journal of Radiation Oncology, Biology, Physics|February 20, 2021
Systematic Screening of COVID-19 Disease Based on Chest CT and RT-PCR for Cancer Patients Undergoing Radiation Therapy in a Coronavirus French HotspotRoger Sun, Samir Achkar, Samy Ammari, et al.
Oncotarget|March 7, 2018
Locally advanced cervical cancer with bladder invasion: clinical outcomes and predictive factors for vesicovaginal fistulaeRoger Sun, Ines Koubaa, Elaine Johanna Limkin, et al.
Pageof 6